The Valley Desk

ArticleMolecular oncologyPublished

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Article
Venue
Molecular oncology
Published
Subject terms
Cell Line, Tumor; Animals; Humans; Mice; DNA Damage; Ascorbic Acid; Poly(ADP-ribose) Polymerases; Drug Synergism; Male; Prostatic Neoplasms, Castration-Resistant; Poly(ADP-ribose) Polymerase Inhibitors; Ascorbate
PubMed ID
41534532
PubMed Central ID
PMC13238595
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal